# The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

Study · id `cardio:ct-nct02411903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02411903](<https://clinicaltrials.gov/study/NCT02411903>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02411903

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT02411903. Randomized; no masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2016-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT02411903, source copy `cardio:ctgov-nct02411903-2015-06-16`, retrieved 2026-10-26)
- Start date: 2015-03 (registry gives no type) (ClinicalTrials.gov record NCT02411903, source copy `cardio:ctgov-nct02411903-2015-06-16`, retrieved 2026-10-26)
- Primary completion: 2016-07 (anticipated) (ClinicalTrials.gov record NCT02411903, source copy `cardio:ctgov-nct02411903-2015-06-16`, retrieved 2026-10-26)
- Completion: 2016-08 (anticipated) (ClinicalTrials.gov record NCT02411903, source copy `cardio:ctgov-nct02411903-2015-06-16`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02411903-2015-06-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
- Condition: Cerebral Infarction
- Condition: Clopidogrel,Poor Metabolism of (Disorder)
- Intervention (Drug): atorvastatin and clopidogrel
- Intervention (Drug): rosuvastatin and clopidogrel
- Lead sponsor: The Third Affiliated Hospital of Guangzhou Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 034df9996540859ed245551e900534de0efcf9732f5e172a8012905065a0932c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
